Select for export Correction: Clinical Pharmacokinetics of Psilocin After Psilocybin Administration: A Systematic Review and Post-Hoc Analysis. No abstract availability was recorded for this entry. Details DOI 10.1007/s40262-025-01487-3 PubMed 39982684 Copy citation Copy BibTeX Unknown journal 2025-02-28 Otto ME, van der Heijden KV, Schoones JW, van Esdonk MJ, Borghans LGJM, Jacobs GE Europe PMC Published psilocybinpsilocin PharmacologySystematic ReviewReview Article Systematic Review More
Select for export Therapeutic Potential of Psychedelics for Treating Anosmia: An Investigation of Online Accounts Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/02791072.2025.2474239 PubMed 40022524 Copy citation Copy BibTeX Journal of Psychoactive Drugs 2025-02-28 Alexsandra Kovacevich, Ian Dorney, Lukas Bobak, David C. Kaelber, Brian S. Barnett OpenAlex Published psilocybin Mechanism of ActionCase Report Case Report More
Select for export Irremediable Psychiatric Suffering, a Potential Indication for Psilocybin Treatment No abstract availability was recorded for this entry. Details DOI 10.1176/appi.ajp.20240121 PubMed 40022534 Copy citation Copy BibTeX American Journal of Psychiatry 2025-02-28 Metten Somers, Floortje E. Scheepers OpenAlex Published psilocybin General Other More
Select for export Psychedelics for Cancer Pain and Associated Psychological Distress: A Narrative Review of a Potential Strategy. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/cam4.70586 PubMed 40052631 Copy citation Copy BibTeX Unknown journal 2025-02-28 Belitzky E, Ravani Carvalho LV, Taylor M, Ortiz CN, Baum L, Fiellin DA Europe PMC Published psilocybin DepressionAnxietyAddiction Clinical Trial More
Select for export Sociodemographic and mental-health characteristics of psychedelic-assisted therapy participants: Latent class analysis of a cross-sectional, purposive online sample Abstract available at the source but not redistributed here. Read at source. Details DOI 10.31234/osf.io/26tz7_v1 Copy citation Copy BibTeX PsyArXiv 2025-02-27 Petrovitch D, Hosford S, Littlefield AK, Austin-Robillard H. PsyArXiv PREPRINT (not peer reviewed) psilocybin DepressionAnxietyClinical Trial Clinical Trial More
Select for export Tū Wairua: Development of an Indigenous Rongoā Māori Approach to Healing with Psilocybin Containing Mushrooms Abstract available at the source but not redistributed here. Read at source. Details DOI 10.31234/osf.io/93x5h_v3 Copy citation Copy BibTeX PsyArXiv 2025-02-27 Hodge A, Forsyth A, Noorani T, Muthukumaraswamy S, Rolleston A, McHugh P. PsyArXiv PREPRINT (not peer reviewed) psilocybin AddictionMechanism of ActionSpirituality Other More
Select for export Sociodemographic and mental-health characteristics of psychedelic-assisted therapy participants: Latent class analysis of a cross-sectional, purposive online sample Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX PsyArXiv 2025-02-27 Authors unavailable PsyArXiv PREPRINT (not peer reviewed) psilocybin DepressionAnxietyPharmacology Clinical Trial More
Select for export Tū Wairua: Development of an Indigenous Rongoā Māori Approach to Healing with Psilocybin Containing Mushrooms Abstract available at the source but not redistributed here. Read at source. Details DOI 10.31234/osf.io/93x5h_v2 Copy citation Copy BibTeX PsyArXiv 2025-02-27 Hodge A, Forsyth A, Noorani T, Muthukumaraswamy S, Rolleston A, McHugh P. PsyArXiv PREPRINT (not peer reviewed) psilocybin AddictionMechanism of ActionSpirituality Other More
Select for export Prolonged adverse effects from repeated psilocybin use in an underground psychedelic therapy training program: a case report Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1186/s12888-024-06303-z PubMed 40021999 Copy citation Copy BibTeX BMC Psychiatry 2025-02-27 John Perna, Justin Trop, Roman Palitsky, Zachary Bosshardt, Helen Vantine, Boadie W. Dunlop OpenAlex Published psilocybin PharmacologyEmotional ProcessingCase Report Case Report More
Select for export Serotonergic Psychedelics Rapidly Modulate Evoked Glutamate Release in Cultured Cortical Neurons Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1111/jnc.70020 PubMed 40022486 Copy citation Copy BibTeX Journal of Neurochemistry 2025-02-27 Aneta Petrušková, Debarpan Guhathakurta, Enes Yağız Akdaş, Bartomeu Perelló-Amorós, Renato Frischknecht, Eva-Maria Weiss OpenAlex Published psilocybinpsilocin DepressionAnxietyAddiction Animal Study More
Select for export Psychedelics are Bringing a new wind to the Pharmacopoeia Abstract available at the source but not redistributed here. Read at source. Details DOI 10.31579/2578-8868/360 Copy citation Copy BibTeX Neuroscience and Neurological Surgery 2025-02-26 Michel Bourin OpenAlex Published psilocybin Clinical Trial Clinical Trial More
Select for export A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1089/psymed.2024.0019 PubMed 40351554 Copy citation Copy BibTeX Unknown journal 2025-02-26 Yaden DB, Graziosi M, Owen AM, Agin-Liebes G, Aaronson ST, Allen KE Europe PMC Published psilocybin Receptor PharmacologyConsciousnessWellbeing Review Article More
Select for export Acute Effects and Pharmacokinetics of LSD after Paroxetine or Placebo Pre-Administration in a Randomized, Double-Blind, Cross-Over Phase I Trial. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/cpt.3618 PubMed 40022427 Copy citation Copy BibTeX Unknown journal 2025-02-26 Becker AM, Humbert-Droz M, Mueller L, Jelušić A, Tolev A, Straumann I Europe PMC Published psilocybin DepressionAnxietyPharmacology Randomized Controlled Trial More
Select for export A review of psychedelics trials completed in depression, informed by European regulatory perspectives. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.nsa.2025.105516 PubMed 40654583 Copy citation Copy BibTeX Unknown journal 2025-02-25 Silva F, Butlen-Ducuing F, Guizzaro L, Balabanov P. Europe PMC Published psilocybin DepressionClinical TrialReview Article Clinical Trial More
Select for export The Impact of Communicating the Benefits and Safety of Psilocybin on Policy Support: A Survey Based Experiment. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.31234/osf.io/48yg7_v2 Copy citation Copy BibTeX PsyArXiv 2025-02-24 Hitchins K, Reynolds J. PsyArXiv PREPRINT (not peer reviewed) psilocybin LongevityObservational StudySafety Observational Study More
Select for export Psilocin, A Psychedelic Drug, Exerts Anticonvulsant Effects Against PTZ- and MES-Induced Seizures in Mice via 5-HT1A and CB1 Receptors: Involvement of Nitrergic, Opioidergic, and Kynurenine Pathways Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/prp2.70079 PubMed 39996441 Copy citation Copy BibTeX Pharmacology Research & Perspectives 2025-02-24 Mohammad Balabandian, Mohammad Amin Manavi, Ali Lesani, Razieh Mohammad Jafari, Hamed Shafaroodi, Neda Heidari OpenAlex Published psilocybinpsilocin AddictionPharmacologyMechanism of Action Animal Study More
Select for export The Impact of Communicating the Benefits and Safety of Psilocybin on Policy Support: A Survey Based Experiment. Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX PsyArXiv 2025-02-24 Authors unavailable PsyArXiv PREPRINT (not peer reviewed) psilocybin LongevityPersonality ChangeObservational Study Observational Study More
Select for export The Impact of Communicating the Benefits and Safety of Psilocybin on Policy Support: A Survey Based Experiment. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.31234/osf.io/48yg7_v1 Copy citation Copy BibTeX PsyArXiv 2025-02-23 Hitchins K, Reynolds J. PsyArXiv PREPRINT (not peer reviewed) psilocybin LongevityObservational StudySafety Observational Study More
Select for export Exploring factors associated with the intensity of a mystical experience following naturalistic psychedelic use: A retrospective survey. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.pnpbp.2025.111300 PubMed 40010428 Copy citation Copy BibTeX Unknown journal 2025-02-23 Romeo B, Kervadec E, Fauvel B, Strika-Bruneau L, Amirouche A, Verroust V Europe PMC Published psilocybin AddictionSpiritualityMystical Experience Observational Study More
Select for export Development and validation of a HPLC-DAD method for determining the content of tryptamines in methanolic extracts of fruiting bodies of mushrooms belonging to species of the Psilocybe genus. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.talanta.2025.127777 PubMed 40020610 Copy citation Copy BibTeX Unknown journal 2025-02-20 Yasmo Perez JP, Chegwin Angarita C, Saldarriaga Ochoa OD, Urrego Restrepo SA. Europe PMC Published psilocin General Clinical Trial More
